Filing excerpt
The decrease in global Prolia sales for the three months ended March 31, 2026 was primarily driven by lower volume of 17%, lower net selling price of 10% and 4% from lower inventory.
Global Prolia sales dropped from $1.1B to $727M year-over-year, driven by a 17% volume loss and lower prices. The company expects 'accelerated sales erosion' from multiple biosimilar competitors, creating significant pressure to offset this major revenue loss.
Filing excerpt
The decrease in global Prolia sales for the three months ended March 31, 2026 was primarily driven by lower volume of 17%, lower net selling price of 10% and 4% from lower inventory.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Regions named
sec-10qcompetitorNamedGet every 10-Q signal for Amgen and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/94a20dae-6555-4a74-acdb-538b05013875 returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.
{
"signal_id": "94a20dae-6555-4a74-acdb-538b05013875",
"signal_type": "sec-10q",
"signal_subtype": "competitorNamed",
"detected_at": "2026-05-05T08:48:22.5+00:00",
"company": {
"name": "Amgen",
"domain": "amgen.com"
},
"data": {
"detail": "Global Prolia sales dropped from $1.1B to $727M year-over-year, driven by a 17% volume loss and lower prices. The company expects 'accelerated sales erosion' from multiple biosimilar competitors, creating significant pressure to offset this major revenue loss.",
"metrics": {
"pct": -0.34,
"timeframe": "current_quarter",
"pct_context": "Year-over-year change in Total Prolia sales for Q1",
"dollar_context": "Year-over-year decrease in Total Prolia sales for Q1",
"dollar_millions": 372
},
"summary": "Prolia sales plummet 34% ($372M) due to biosimilar competition after patent expiry.",
"excerpts": "The decrease in global Prolia sales for the three months ended March 31, 2026 was primarily driven by lower volume of 17%, lower net selling price of 10% and 4% from lower inventory.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000057/amgn-20260331.htm",
"filing_date": "2026-04-30",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Competitive intelligence",
"signal_category": "market",
"regions_mentioned": [
"U.S.",
"ROW"
],
"technologies_mentioned": [
"biosimilars"
]
}
}
curl https://signals.autobound.ai/v1/signals/94a20dae-6555-4a74-acdb-538b05013875 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"amgen.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.